# Kindos Pharmaceuticals Co., Ltd. – FDA Inspection, Apr 1, 2017

Source: https://www.keypedia.com/records/fda_inspections/kindos-pharmaceuticals-co-ltd/8c645e62-a8ca-4341-9397-64df42393ed5
Source feed: FDA_Inspections

> FDA inspection 1009271 of Kindos Pharmaceuticals Co., Ltd., April 01, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1009271
- Company Name: Kindos Pharmaceuticals Co., Ltd.
- Inspection Date: 2017-04-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1244269 - 2024-07-19](https://www.keypedia.com/records/fda_inspections/kindos-pharmaceuticals-co-ltd/243d6f36-52b7-432b-841d-577271f5d963)
- FDA Inspection 1101348 - 2019-07-30
- FDA Inspection 978257 - 2016-06-02
- [FDA Inspection 941452 - 2015-04-10](https://www.keypedia.com/records/fda_inspections/kindos-pharmaceuticals-co-ltd/4d49c3d0-b93e-4c8f-a9b6-d55d651f156a)
- FDA Inspection 807892 - 2012-07-24

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/lane-v-christensen/fb30085e-494e-460e-9f3d-c480902d6468)
- [FDA Associated Person](https://www.keypedia.com/people/peter-e-baker/c32eb848-de28-4725-80c9-ef8548d445bf)

Company: https://www.keypedia.com/companies/kindos-pharmaceuticals-co-ltd/a5fd0a47-2dba-4a4d-a030-877525533def

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c